Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ February 3, 2023 ] Postdoctoral Fellow – Computational Biology, Computational Chemistry, Bioinformatics – City of Hope – Duarte, CA Los Angeles Biotech Jobs
  • [ February 3, 2023 ] Research Associate – AdvanBio – Irvine, CA Los Angeles Biotech Jobs
  • [ February 3, 2023 ] Staff Research Associate I – Biological Chemistry – UCLA Health – Los Angeles, CA Los Angeles Biotech Jobs
  • [ February 3, 2023 ] Laboratory Director – Somatic Curation – Fulgent Therapeutics Llc – El Monte, CA Los Angeles Biotech Jobs
  • [ February 2, 2023 ] Director, Regulatory Affairs CMC – Cell Therapy – Kite Pharma – Santa Monica, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsAmgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers

March 30, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers
Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers aalidrus Tue, 03/30/2021 - 17:07

Click to view original post

Previous

Going head-to-head with Merck on I/O, Genentech vets raise fresh round and enter clinic

Next

ChromaDex and the Citrin Foundation Announce Global Research Collaboration Exploring Citrin Deficiency

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered